125 related articles for article (PubMed ID: 37739730)
1. Efficacy of beta-hydroxy-beta-methylbutyrate, arginine, and glutamine for the prevention of mucositis induced by platinum-based chemoradiation in head and neck cancer: A phase II study.
Kuroki K; Rikimaru F; Kunitake N; Toh S; Higaki Y; Masuda M
Clin Nutr ESPEN; 2023 Oct; 57():730-734. PubMed ID: 37739730
[TBL] [Abstract][Full Text] [Related]
2. A phase II study of HMB/Arg/Gln against oral mucositis induced by chemoradiotherapy for patients with head and neck cancer.
Yokota T; Hamauchi S; Yoshida Y; Yurikusa T; Suzuki M; Yamashita A; Ogawa H; Onoe T; Mori K; Onitsuka T
Support Care Cancer; 2018 Sep; 26(9):3241-3248. PubMed ID: 29627862
[TBL] [Abstract][Full Text] [Related]
3. Effect of HMB/Arg/Gln on the prevention of radiation dermatitis in head and neck cancer patients treated with concurrent chemoradiotherapy.
Imai T; Matsuura K; Asada Y; Sagai S; Katagiri K; Ishida E; Saito D; Sadayasu R; Wada H; Saijo S
Jpn J Clin Oncol; 2014 May; 44(5):422-7. PubMed ID: 24688085
[TBL] [Abstract][Full Text] [Related]
4. Reversal of cancer-related wasting using oral supplementation with a combination of beta-hydroxy-beta-methylbutyrate, arginine, and glutamine.
May PE; Barber A; D'Olimpio JT; Hourihane A; Abumrad NN
Am J Surg; 2002 Apr; 183(4):471-9. PubMed ID: 11975938
[TBL] [Abstract][Full Text] [Related]
5. Beta-hydroxy beta-methylbutyrate/arginine/glutamine (HMB/Arg/Gln) supplementation to improve the management of cachexia in patients with advanced lung cancer: an open-label, multicentre, randomised, controlled phase II trial (NOURISH).
Pascoe J; Jackson A; Gaskell C; Gaunt C; Thompson J; Billingham L; Steven N
BMC Cancer; 2021 Jul; 21(1):800. PubMed ID: 34247580
[TBL] [Abstract][Full Text] [Related]
6. Perioperative Nutritional Support With Beta-hydroxy-beta-methylbutyrate, Arginine, and Glutamine in Surgery for Abdominal Malignancies.
Wada N; Kurokawa Y; Tanaka K; Miyazaki Y; Makino T; Takahashi T; Wada H; Yamasaki M; Yamasaki M; Nakajima K; Eguchi H; Takiguchi S; Mori M; Doki Y
Wounds; 2018 Sep; 30(9):251-256. PubMed ID: 30256751
[TBL] [Abstract][Full Text] [Related]
7. A randomized, double-blind, placebo-controlled trial of a beta-hydroxyl beta-methyl butyrate, glutamine, and arginine mixture for the treatment of cancer cachexia (RTOG 0122).
Berk L; James J; Schwartz A; Hug E; Mahadevan A; Samuels M; Kachnic L;
Support Care Cancer; 2008 Oct; 16(10):1179-88. PubMed ID: 18293016
[TBL] [Abstract][Full Text] [Related]
8. Nutritional treatment for acquired immunodeficiency virus-associated wasting using beta-hydroxy beta-methylbutyrate, glutamine, and arginine: a randomized, double-blind, placebo-controlled study.
Clark RH; Feleke G; Din M; Yasmin T; Singh G; Khan FA; Rathmacher JA
JPEN J Parenter Enteral Nutr; 2000; 24(3):133-9. PubMed ID: 10850936
[TBL] [Abstract][Full Text] [Related]
9. Dietary treatment of rheumatoid cachexia with beta-hydroxy-beta-methylbutyrate, glutamine and arginine: a randomised controlled trial.
Marcora S; Lemmey A; Maddison P
Clin Nutr; 2005 Jun; 24(3):442-54. PubMed ID: 15896432
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the recovery after heart surgery following preoperative supplementation with a combination of beta-hydroxy-beta-methylbutyrate, L-arginine, and L-glutamine: a double-blind randomized placebo-controlled clinical trial.
Norouzi M; Nadjarzadeh A; Maleki M; Khayyatzadeh SS; Hosseini S; Yaseri M; Fattahi H
Trials; 2022 Aug; 23(1):649. PubMed ID: 35964137
[TBL] [Abstract][Full Text] [Related]
11. L-glutamine decreases the severity of mucositis induced by chemoradiotherapy in patients with locally advanced head and neck cancer: a double-blind, randomized, placebo-controlled trial.
Tsujimoto T; Yamamoto Y; Wasa M; Takenaka Y; Nakahara S; Takagi T; Tsugane M; Hayashi N; Maeda K; Inohara H; Uejima E; Ito T
Oncol Rep; 2015 Jan; 33(1):33-9. PubMed ID: 25351453
[TBL] [Abstract][Full Text] [Related]
12. Amelioration of radiation-induced acute inflammation and mucosal atrophy by beta-hydroxy-beta-methylbutyrate, L-glutamıne, and L-argınıne: results of an experimental study.
Yavas C; Yavas G; Acar H; Toy H; Yuce D; Akyurek S; Ata O
Support Care Cancer; 2013 Mar; 21(3):883-8. PubMed ID: 22993027
[TBL] [Abstract][Full Text] [Related]
13. Gut microbiome predicts gastrointestinal toxicity outcomes from chemoradiation therapy in patients with head and neck squamous cell carcinoma.
Hes C; Desilets A; Tonneau M; El Ouarzadi O; De Figueiredo Sousa M; Bahig H; Filion É; Nguyen-Tan PF; Christopoulos A; Benlaïfaoui M; Derosa L; Alves Costa Silva C; Ponce M; Malo J; Belkad W; Charpentier D; Aubin F; Hamilou Z; Jamal R; Messaoudene M; Soulières D; Routy B
Oral Oncol; 2024 Jan; 148():106623. PubMed ID: 38006691
[TBL] [Abstract][Full Text] [Related]
14. Beta-hydroxy-beta-methylbutyrate supplementation in critically ill trauma patients.
Kuhls DA; Rathmacher JA; Musngi MD; Frisch DA; Nielson J; Barber A; MacIntyre AD; Coates JE; Fildes JJ
J Trauma; 2007 Jan; 62(1):125-31; discussion 131-2. PubMed ID: 17215743
[TBL] [Abstract][Full Text] [Related]
15. Oral mucositis prevention by low-level laser therapy in head-and-neck cancer patients undergoing concurrent chemoradiotherapy: a phase III randomized study.
Gouvêa de Lima A; Villar RC; de Castro G; Antequera R; Gil E; Rosalmeida MC; Federico MH; Snitcovsky IM
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):270-5. PubMed ID: 21163585
[TBL] [Abstract][Full Text] [Related]
16. Supplementation with a combination of beta-hydroxy-beta-methylbutyrate (HMB), arginine, and glutamine is safe and could improve hematological parameters.
Rathmacher JA; Nissen S; Panton L; Clark RH; Eubanks May P; Barber AE; D'Olimpio J; Abumrad NN
JPEN J Parenter Enteral Nutr; 2004; 28(2):65-75. PubMed ID: 15080599
[TBL] [Abstract][Full Text] [Related]
17. Comparison of acute toxicities associated with cetuximab-based bioradiotherapy and platinum-based chemoradiotherapy for head and neck squamous cell carcinomas: A single-institution retrospective study in Japan.
Sakashita T; Homma A; Hatakeyama H; Furusawa J; Kano S; Mizumachi T; Iizuka S; Onimaru R; Tsuchiya K; Yasuda K; Shirato H; Fukuda S
Acta Otolaryngol; 2015 Aug; 135(8):853-8. PubMed ID: 25814008
[TBL] [Abstract][Full Text] [Related]
18. A phase 1 trial of Vorinostat in combination with concurrent chemoradiation therapy in the treatment of advanced staged head and neck squamous cell carcinoma.
Teknos TN; Grecula J; Agrawal A; Old MO; Ozer E; Carrau R; Kang S; Rocco J; Blakaj D; Diavolitsis V; Kumar B; Kumar P; Pan Q; Palettas M; Wei L; Baiocchi R; Savvides P
Invest New Drugs; 2019 Aug; 37(4):702-710. PubMed ID: 30569244
[TBL] [Abstract][Full Text] [Related]
19. A randomized phase 3 trial comparing nimotuzumab plus cisplatin chemoradiotherapy versus cisplatin chemoradiotherapy alone in locally advanced head and neck cancer.
Patil VM; Noronha V; Joshi A; Agarwal J; Ghosh-Laskar S; Budrukkar A; Murthy V; Gupta T; Mahimkar M; Juvekar S; Arya S; Mahajan A; Agarwal A; Purandare N; Rangarajan V; Balaji A; Chaudhari SV; Banavali S; Kannan S; Bhattacharjee A; D'Cruz AK; Chaturvedi P; Pai PS; Chaukar D; Pantvaidya G; Nair D; Nair S; Deshmukh A; Thiagarajan S; Mathrudev V; Manjrekar A; Dhumal S; Maske K; Bhelekar AS; Nawale K; Chandrasekharan A; Pande N; Goel A; Talreja V; Simha V; Srinivas S; Swami R; Vallathol DH; Dsouza H; Shrirangwar S; Turkar S; Abraham G; Thanky AH; Patel U; Pandey MK; Prabhash K
Cancer; 2019 Sep; 125(18):3184-3197. PubMed ID: 31150120
[TBL] [Abstract][Full Text] [Related]
20. Effects of supplementation with a combination of β-hydroxy-β-methyl butyrate, L-arginine, and L-glutamine on postoperative recovery of quadriceps muscle strength after total knee arthroplasty.
Nishizaki K; Ikegami H; Tanaka Y; Imai R; Matsumura H
Asia Pac J Clin Nutr; 2015; 24(3):412-20. PubMed ID: 26420181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
